CO [Chinard Bloodrp] SC TO-C: (Original Filing)

[SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section14(d)(1) or 13(e)(1) CHINARD BLOODRPORATION (Name of Subjectmpany (Issuer) and Name of Filing Person (Issuer)) (Title of Class of Securities)G211071181 )bert Chen +852 3605 8180bert.chen@chinacordbloodcorp.com 48th Floor, Bank of China Tower 1 Garden Road Central, Hong KongR.] [HONG KONG, China, September 13, 2010 - Chinard Bloodrporation Ms. Ting Zheng, Chairperson and CEO of Chinard Bloodrporationmmented, The proposed exchange offer will streamline and simplify our shareholding structure wellrporate structure.out Chinard Bloodrporation http://www.chinacordbloodcorp.com Chinard Bloodrporation is the first and largestrd blood banking operator in China in terms of geographicalverage and is the onlyrd blood]

By | 2016-02-04T18:43:08+00:00 September 13th, 2010|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] SC TO-C: SCHEDULE TO (Rule 14d-100) Tender Offer Statement under

[SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section14(d)(1) or 13(e)(1) CHINARD BLOODRPORATION (Name of Subjectmpany (Issuer) and Name of Filing Person (Issuer)) (Title of Class of Securities)G211071181 )bert Chen +852 3605 8180bert.chen@chinacordbloodcorp.com 48th Floor, Bank of China Tower 1 Garden Road Central, Hong KongR.] [HONG KONG, China, September 13, 2010 - Chinard Bloodrporation Ms. Ting Zheng, Chairperson and CEO of Chinard Bloodrporationmmented, The proposed exchange offer will streamline and simplify our shareholding structure wellrporate structure.out Chinard Bloodrporation http://www.chinacordbloodcorp.com Chinard Bloodrporation is the first and largestrd blood banking operator in China in terms of geographicalverage and is the onlyrd blood]

By | 2016-02-04T18:43:37+00:00 September 13th, 2010|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] 6-K: (Original Filing)

[HONG KONG, China, September 13, 2010 - Chinard Bloodrporation Ms. Ting Zheng, Chairperson and CEO of Chinard Bloodrporationmmented, The proposed exchange offer will streamline and simplify our shareholding structure wellrporate structure.out Chinard Bloodrporation http://www.chinacordbloodcorp.com Chinard Bloodrporation is the first and largestrd blood banking operator in China in terms of geographicalverage and is the onlyrd blood]

By | 2016-02-04T18:44:58+00:00 September 13th, 2010|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] 6-K: HONG KONG, China, September 13, 2010 – Chinard

[HONG KONG, China, September 13, 2010 - Chinard Bloodrporation Ms. Ting Zheng, Chairperson and CEO of Chinard Bloodrporationmmented, The proposed exchange offer will streamline and simplify our shareholding structure wellrporate structure.out Chinard Bloodrporation http://www.chinacordbloodcorp.com Chinard Bloodrporation is the first and largestrd blood banking operator in China in terms of geographicalverage and is the onlyrd blood]

By | 2016-02-04T18:45:27+00:00 September 13th, 2010|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: (Original Filing)

[China Cord Blood Corporation Reports First Quarter Fiscal 2011 Financial Results Revenue Increases 23.8% to RMB71.7 Million RMB17.6 Million Net Income Attributable to Shareholders Conference Call to be Held at 8am ET September 10, 2010 HONG KONG, China, September 10, 2010 — China Cord Blood Corporation (NYSE: CO) (“CCBC” or “the Company”), China’s leading provider of cord blood collection, laboratory]

By | 2016-02-29T16:44:23+00:00 September 10th, 2010|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: China Cord Blood Corporation Reports First Quarter Fiscal

[China Cord Blood Corporation Reports First Quarter Fiscal 2011 Financial Results Revenue Increases 23.8% to RMB71.7 Million RMB17.6 Million Net Income Attributable to Shareholders Conference Call to be Held at 8am ET September 10, 2010 HONG KONG, China, September 10, 2010 — China Cord Blood Corporation (NYSE: CO) (“CCBC” or “the Company”), China’s leading provider of cord blood collection, laboratory]

By | 2016-02-29T16:45:52+00:00 September 10th, 2010|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] 6-K: (Original Filing)

[Chinard Bloodrporation Reports First Quarter Fiscal 2011 Financial Results Revenuereases 23.8% to RMB71.7 Million RMB17.6 Million Netome Attributable to Shareholdersnferencell to be Held at 8am ET September 10, 2010 HONG KONG, China, September 10, 2010 Chinard Bloodrporation (NYSE:) (CCBC or thempany), Chinas leading provider ofrd bloodllection, laboratory testing, hematopoietic stem cell processing, and stem cell]

By | 2016-02-04T18:46:46+00:00 September 10th, 2010|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] 6-K: Chinard Bloodrporation Reports First Quarter Fiscal 2011 Financial

[Chinard Bloodrporation Reports First Quarter Fiscal 2011 Financial Results Revenuereases 23.8% to RMB71.7 Million RMB17.6 Million Netome Attributable to Shareholdersnferencell to be Held at 8am ET September 10, 2010 HONG KONG, China, September 10, 2010 Chinard Bloodrporation (NYSE:) (CCBC or thempany), Chinas leading provider ofrd bloodllection, laboratory testing, hematopoietic stem cell processing, and stem cell]

By | 2016-02-04T18:47:15+00:00 September 10th, 2010|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] SC 13G/A: (Original Filing)

[(Name of Issuer) Ordinary Shares, $0.0001 par value (Title of Class of Securities) G21107100 (CUSIP Number) September 1, 2010 (Date of Event Which Requires Filing of this Statement) o Rule 13d-1(b) þ Rule 13d-1(c) o Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the]

By | 2016-02-29T16:46:37+00:00 September 3rd, 2010|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] SC 13G/A: (Original Filing)

[(Name of Issuer) Ordinary Shares, $0.0001 par value (Title of Class of Securities) G21107100 (CUSIPNumber) September 1, 2010 (Date of Event Which Requires Filing of this Statement) o Rule 13d-1(b) Rule 13d-1(c) o Rule 13d-1(d) *The remainder of thisver page shall be filled out for a reporting person's initial filing on this form with respect]

By | 2016-02-04T18:48:09+00:00 September 3rd, 2010|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar